Article
Association of estrogen receptor-beta (ESR2) polymorphism and cancer risk: a meta-analysis.
European journal of gynaecological oncology - 1 Aug 2016
Xia Wenkai, Wang Tianyl, Sun Dong, Mao Weidong, Xie Xiangcheng
Abstract excerpt
Estrogen signal medicated by estrogen receptor (ER), which is involved in various diseases related to steroid hormone, such as cancer. A number of association studies have focused on ESR2 polymorphisms to investigate the relationship with cancer risk. However, the results are inconsistent and inconclusive. To examine this controversy, 33 studies were enrolled for the pooled analysis for three poly-morphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
